Drug intelligence / Profile preview

Anopyxis klaineana extract

Development stage
Preclinical
Lead developer
Technological University of the Shannon: Midlands Midwest
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

Anopyxis klaineana extract is a botanical extract derived from the stem bark of the West African ethnomedicinal tree *Anopyxis klaineana*. It is primarily being investigated for its potential therapeutic applications as an antiparasitic agent against *Trypanosoma brucei*, the causative agent of African trypanosomiasis (sleeping sickness). In vitro and in silico studies have demonstrated that the extract and its active fractions (such as hexane, chloroform, and ethyl acetate) exhibit significant antitrypanosomal activity. The mechanism of action is believed to involve the inhibition of key parasite enzymes, specifically trypanothione reductase (TR) and uridine diphosphate galactose 4'-epimerase (TbGalE), which are essential for the parasite's survival. Additionally, the extract has shown potential anti-inflammatory, analgesic, and antidepressant-like properties in preclinical animal models.

Other names
Anopyxis klaineana stem bark extractEAK
02

Targets

Trypanothione reductaseGALE (UDP-galactose 4-epimerase)

Beyond the preview

Go deeper on Anopyxis klaineana extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anopyxis klaineana extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call